参考文献/References:
[1] Wysokinski WE,McBane RD,Daniels PR,et al.Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation[J].Mayo Clinic Proc,2008,83(6):639-645.
[2] James D,Alex C,Frederick A,et al.Perioperative management of antithrombotic therapy:Antithrnmbotic therapy and prevention of thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].2012,141(2 suppl):326-350.
[3] Kovacs MJ,Kearon C,Rodger M,et al.Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin[J].Circulation,2004,110(12):1658-1663.
[4] Larson BJ,Zumberg MS,Kitchens CS.A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk[J].Chest,2005,127(3):922-927.
[5] Douketis JD,Johnson JA,Turpie AG.Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin:assessment of a standardized periprocedural anticoagulation regimen[J].Arch Intern Med,2004,164(12):1319-1326.
[6] 张孝静,傅武平.老年髋部骨折术后抗凝治疗的临床观察及护理[J].中医正骨,2013,25(5):76.
[7] 万华,罗漫丽,魏润玲.股骨近端防旋髓内钉治疗合并阿尔茨海默病的股骨转子间骨折的围手术期护理[J].中医正骨,2014,26(1):77-78.
[8] Ansell J,Hirsh J,Hylek E,et al.Pharmacology and management of the vitamin K antagonists:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition)[J].Chest,2008,133(6 Suppl):160-198.
相似文献/References:
[1]易春智,陈锦伦,李肇宏,等.利伐沙班与依诺肝素钠对髋膝关节置换术后
下肢深静脉血栓形成及围手术期隐性失血的影响[J].中医正骨,2016,28(01):17.
YI Chunzhi,CHEN Jinlun,LI Zhaohong,et al.Influence of Rivaroxaban and enoxaparin sodium on lower extremity deep venous thrombosis after total hip&knee arthroplasty and perioperative hidden blood loss[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(03):17.
[2]何雪花.快速康复外科理念在膝关节镜手术围手术期护理中的应用[J].中医正骨,2017,29(02):79.